LGNDLigand Pharmaceuticals Incorporated

$303.51+68% 1Y

Is it safe?

Good

Strong, no red flags: a safe balance sheet and comfortable debt (AA).

2 good, 2 neutral, 2 without data
SurvivalSafe zone

Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Insider conviction-$16.1M

Insiders were net sellers (-$16.1M, 90 days to Oct 22, 2026), selling is often routine.

Credit gradeAAderived · Jun 30, 2026

Net cash and profitable. A rule of thumb on leverage, not a credit rating.

Drawdown risk38% volderived · Oct 23, 2026

Moderate price swings, typical volatility. Worst drawdown -77% · now 6% below its 52-week high.

Unless marked, from SEC EDGAR, as of Dec 31, 2025.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitymiddle of the market
Max drawdownbehind 69% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can LGND take a bad year?

Ligand Pharmaceuticals Incorporated holds $231M more cash than debt, so a bad year is a question about profits, not about lenders.

$231M

Net cash · as at Q2 2026 · cash and short-term investments less total debt

Net debt / EBITDA
net cash

Net debt / EBITDA · no net borrowings to measure against earnings

Altman Z-score
8.10

Altman Z-score · safe zone, above 3

Interest cover
15.3×

Interest cover · operating profit covers the interest bill several times over

Details›
Total debtQ2 2026
$1.13B
Cash and short-term investments
$1.36B
Net cash
$231M
EBITDA, trailing twelve months
$128M
Operating profit, trailing twelve months
$95M
Debt / equity
1.16×
Total debt / EBITDA
8.83×
Annualised volatilitytwo years of daily moves
38%
Worst drawdown on file
−77%
Below its 52-week high
5.9%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.

The balance sheet

What it owes against what it owns, and how close that comes to trouble.

How far can it fall?

How much the price moves, how deep and how long its falls have run, and what each unit of risk has paid.